Combined intravitreal bevacizumab and argon laser treatment for Coats' disease

Acta Ophthalmologica

Volumn 88, Issue 2, 2010, Pages

  Cackett, Peter ^a,b   Wong, Doric ^b   Cheung, Chui Ming Gemmy ^b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADOLESCENT; ANAMNESIS; ARGON LASER; CASE REPORT; CLINICAL FEATURE; EXUDATIVE RETINITIS; EYE EXAMINATION; HUMAN; LASER COAGULATION; LETTER; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; VISUAL ACUITY;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; LASER COAGULATION; LASERS, GAS; MALE; RETINAL DISEASES; RETINAL VESSELS; TELANGIECTASIS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77649206199     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01514.x     Document Type: Letter

References (11)

1. ®). Arch Soc Esp Oftalmol 83 : 329 332.
2. Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 1695 e1 e15.
3. Cakir M, Cekic O Yilmaz OF (2008 Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 12 : 309 311.
4. Fang X, Sakaguchi H, Gomi F et al. (2008 Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 800 805.
5. Harris GS (1970 Coats' disease, diagnosis and treatment. Can J Ophthalmol 5 : 311 320.
6. Kernt M, Neubauer AS Kampik A (2007 Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure. Acta Ophthalmol Scand 85 : 119 120. (Pubitemid 46140172)
7. Kiratli H Eldem B (1998 Management of moderate to advanced Coats' disease. Ophthalmologica 212 : 19 22.
8. Shima C, Sakaguchi H, Gomi F et al. (2008 Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 : 372 376.
9. Sun Y, Jain A Moshfeghi DM (2007 Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 245 : 1387 1388.
10. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU Jorge R (2008 Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86 : 385 389.
11. Venkatesh P, Mandal S Garg S (2008 Management of Coats disease with bevacizumab in 2 patients. Can J Ophthalmol 43 : 245 246.